secwatch.observer — SEC 8-K summary
======================================

Issuer:     IO Biotech, Inc. (IOBTQ)
CIK:        0001865494
Form:       8-K
Filed at:   2026-02-13T23:59:59+00:00
Accession:  0001193125-26-051790
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

IO Biotech receives Nasdaq MVLS deficiency notice; 180 days to comply
---------------------------------------------------------------------

- Notice received Feb 12, 2026; MVLS below $50M for 30 consecutive business days.
- Company has until August 11, 2026 to regain compliance.
- Stock continues trading on Nasdaq Global Select Market during cure period.
- If not cured, Nasdaq will issue delisting notice; company may appeal.
- No assurance of regaining compliance with MVLS or other listing rules.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1865494/000119312526051790/0001193125-26-051790-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1865494/000119312526051790/d113832d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-051790

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer